FrancophonIA/ELRC3.0 huggingface dataset:
English: Optaflu is available in packs containing 1 or 10 pre-filled syringes and in multipacks comprising 2 cartons, each containing 10 pre-filled syringes.
Danish: Optaflu findes i pakninger, der indeholder 1 eller 10 fyldte injektionssprøjter, og i flerstykspakninger, der indeholder 2 kartoner a 10 fyldte injektionssprøjter.
English: The PSUR cycle for the medicinal product should follow a twice-yearly cycle until otherwise agreed
Danish: • Periodiske, opdaterede sikkerhedsindberetninger (PSUR'er) Lægemidlets PSUR-cyklus skal følge en 2-årig cyklus, indtil andet aftales med CHMP.
English: Optaflu may have a minor effect on your ability to drive and use machines.
Danish: Optaflu kan i mindre grad påvirke Deres evne til at føre motorkøretøj og betjene maskiner.
English: As with all injectable vaccines, appropriate medical treatment and supervision should always be readily available in case of a rare anaphylactic event following the administration of the vaccine.
Danish: 4.4 Særlige advarsler og forsigtighedsregler vedrørende brugen Som med alle injicerbare vacciner skal relevant medicinsk behandling samt overvågning altid være let tilgængelige i tilfælde af en sjælden anafylaktisk reaktion efter administration af vaccinen.
English: Other medicines and Optaflu
Danish: Brug af anden medicin sammen med Optaflu
English: Uncommon (affects 1 to 10 users in 1,000): • generalised skin reactions such as itching, bumps on the skin or non-specific rash
Danish: Ikke almindelige (forekommer hos 1 til 10 brugere ud af 1.000): • generelle hudreaktioner, herunder kløe, knopper på huden eller ikke-specifikt udslæt.
English: • flu-like symptoms such as headache, feeling of discomfort, tiredness, muscle pain.
Danish: • influenzalignende symptomer som hovedpine, utilpashed, træthed, muskelsmerter
English: No effects on the breastfed newborn /infant are anticipated.
Danish: Der forventes ingen påvirkning af det ammede barn.
English: This reaction may occur with Optaflu as with all vaccines that are injected.
Danish: Sådanne reaktioner opstår dog kun sjældent, men de kan forekomme med Optaflu ligesom med alle andre vacciner, som indsprøjtes.
English: Tell the doctor requesting the test that you have recently received Optaflu.
Danish: Fortæl den læge, der bestiller prøven, at De har
English: ** Seroconversion = negative pre-vaccination HI titer and post-vaccination HI titer ≥40; significant increase = positive pre-vaccination HI titer and at least a 4-fold increase in post-vaccination HI titer.
Danish: ** Serokonvertering = negativ prævaccinations HI-titer og postvaccinations HI-titer ≥ 40; signifikant stigning = positiv prævaccinations-HI-titer og mindst en stigning med faktor 4 i postvaccinations-HI-titer.
English: None of the ingredients in the vaccine can
Danish: Ingen af indholdsstofferne i vaccinen kan forårsage influenza.
English: 15 micrograms HA** 15 micrograms HA** per 0.5 ml dose
Danish: 15 mikrogram HA** 15 mikrogram HA** pr. 0,5 ml dosis
English: • weakness beginning in the legs and progressing to the arms with numbness and tingling sensation which are symptoms of an inflammation of the nerves
Danish: • kraftesløshed, som starter i benene og breder sig til armene med følelsesløshed og en prikkende fornemmelse, hvilket er symptomer på nervebetændelse.
English: The incidence rates for moderate and severe pain after Optaflu vaccination are similar to those of egg-derived influenza vaccines; however a slightly increased risk for mild short-lasting injection site pain was observed with Optaflu in the subgroup of elderly vaccinees (8% compared to 6% with egg-derived influenza vaccine).
Danish: Der er dog en let øget risiko for lette, kortvarige smerter på injektionsstedet i undergruppen af ældre vaccinerede (8 % med Optaflu sammenlignet med 6 % med ægderiverede influenzavacciner).
English: Table 2: Vaccine Efficacy against Culture-Confirmed Influenza Attack Rate (%)
Danish: Tabel 2: Vaccinens virkning mod kulturbekræftet influenza
English: Uncommon ≥ 1/1000 to
Danish: Ikke almindelige ≥ 1/1.000 til
English: The other ingredients are: sodium chloride, potassium chloride, magnesium chloride hexahydrate, disodium phosphate dihydrate, potassium dihydrogen phosphate and water for injections.
Danish: Øvrige indholdsstoffer: natriumchlorid, kaliumchlorid, magnesiumchloridhexahydrat, dinatriumphosphatdihydrat, kaliumdihydrogenphosphat og vand til injektionsvæsker.
English: MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS Prefilled syringe
Danish: MINDSTEKRAV TIL MÆRKNING, PÅ SMÅ INDRE EMBALLAGER Fyldt injektionssprøjte
English: Reporting of suspected adverse reactions after authorisation of the medicinal products is important.
Danish: Når lægemidlet er godkendt, er indberetning af formodede bivirkninger vigtig.
English: Also, tell your doctor immediately if you experience any of the following side effects - you may need
Danish: Søg også omgående læge, hvis De får nogen af følgende bivirkninger - De kan have brug for lægehjælp:
English: The persistence of postvaccination antibodies to strains included in the vaccine is usually 6-12 months, as shown by studies performed during the clinical development of this vaccine.
Danish: Studier gennemført under den kliniske udvikling af denne vaccine har vist, at immuniteten over for de stammer, der er inkluderet i vaccinen, normalt persisterer 6-12 måneder efter vaccinationen.
English: * produced in Madin Darby Canine Kidney (MDCK) cells (this is the special cell culture in which the influenza virus is grown) ** haemagglutinin
Danish: * fremstillet i Madin Darby Canine Kidney (MDCK) celler (den specielle kultur, hvor
English: Very rare (affects less than 1 user in 10,000):
Danish: Meget sjældne (forekommer hos færre end 1 bruger ud af 10.000):
English: Rare (affects 1 to 10 users in 10,000):
Danish: Sjældne (forekommer hos 1 til 10 brugere ud af 10.000):
English: 15 micrograms HA** per 0.5 ml dose
Danish: 15 mikrogram HA** pr. 0,5 ml dosis
English: • fever, headache, vomiting and drowsiness progressing to coma or fits (convulsions) which are symptoms of an inflammation of the brain and spinal cord
Danish: • feber, hovedpine, opkastning og døsighed, som udvikler sig til koma eller kramper, hvilket er symptomer på betændelse i hjernen eller rygmarven
English: Tell your doctor if you are pregnant, think you may be pregnant or plan to become pregnant.
Danish: Hvis De er gravid eller ammer, har mistanke om, at De er gravid, eller planlægger at blive gravid, skal De spørge Deres læge til råds, før De får Optaflu.
English: • injection site pain, reddening.
Danish: • smerter på injektionsstedet, rødme.
English: Vaccine efficacies against vaccine-matched influenza viral strains, against all influenza viral strains, and against individual influenza viral subtypes were
Danish: Vaccinens virkning mod influenzavirusstammer, der matcher vaccinen, mod alle influenzavirusstammer og mod de enkelte undertyper af influenzavirus blev beregnet (tabel 2 og 3).
English: Sodium chloride, potassium chloride, magnesium chloride hexahydrate, disodium phosphate dihydrate, potassium dihydrogen phosphate and water for injections.
Danish: Natriumchlorid, kaliumchlorid, magnesiumchloridhexahydrat, dinatriumphosphatdihydrat, kaliumdihydrogenphosphat og vand til injektionsvæsker.
English: Animal data have not shown effects on female fertility.
Danish: Data fra dyreforsøg har ikke vist påvirkning af frugtbarheden hos hundyr.
English: Very common (affects more than 1 user in 10):
Danish: Meget almindelige (forekommer hos flere end 1 bruger ud af 10):
English: 10 pre-filled syringes without needle.
Danish: 10 fyldte injektionssprøjter uden kanyle.
English: - Neurological disorders, such as Guillain Barré syndrome, encephalomyelitis and neuritis
Danish: GuillainBarrés syndrom, encefalomyelit og nervebetændelse
English: Tell your doctor or nurse if you are using, have recently used or might use any other medicines, including medicines obtained without a prescription or if you have recently received any other
Danish: Fortæl altid lægen eller sundhedspersonalet, hvis De bruger anden medicin eller har gjort det for nylig.
English: Multipack: 20 (2 packs of 10) pre-filled syringes (0.5 ml) without needle Multipack: 20 (2 packs of 10) pre-filled syringes (0.5 ml) with needle
Danish: Flerstykspakning: 20 (2 pakninger a 10 stk.) fyldte injektionssprøjter (0,5 ml) uden kanyle Flerstykspakning: 20 (2 pakninger a 10 stk.) fyldte injektionssprøjter (0,5 ml) med kanyle
English: Suspension for injection in pre-filled syringe.
Danish: Injektionsvæske, suspension i fyldt injektionssprøjte.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Influenza virus surface antigens (haemagglutinin and neuraminidase)*, inactivated, of the following
Danish: KVALITATIV OG KVANTITATIV SAMMENSÆTNING Influenzavirus-overfladeantigener (hæmagglutinin og neuraminidase)*, inaktiverede, fra følgende
English: Pack sizes of 1, 10 or multipacks containing 20 (2 packs of 10) pre-filled syringes, each with or
Danish: Pakningsstørrelser med 1 eller 10 eller flerstykspakninger med 20 (2 pakninger a 10 stk.) fyldte injektionssprøjter, alle med eller uden kanyler.
English: Optaflu should under no circumstances be injected
Danish: Optaflu må under ingen omstændigheder indsprøjtes i en blodåre.
English: The vaccine targets three strains of influenza virus following the recommendations by the World Health Organisation for the 2015/2016 season.
Danish: Vaccinen er rettet mod tre influenzavirusstammer efter Verdenssundhedsorganisationens (WHO's)
English: Optaflu may be used during breast feeding.
Danish: Optaflu kan anvendes under amning.
English: Keep the pre-filled syringe in the outer carton in order to protect
Danish: Opbevar den fyldte injektionssprøjte i den ydre karton for at
English: Animal studies do not indicate reproductive toxicity (see Section 5.3 - Preclinical safety data).
Danish: Dyrestudier indikerer ikke reproduktionstoksicitet (se pkt.
English: 10 pre-filled syringes with needle.
Danish: 10 fyldte injektionssprøjter med kanyle.
English: 4.5 Interaction with other medicinal products and other forms of interaction Optaflu may be given at the same time as other vaccines.
Danish: 4.5 Interaktion med andre lægemidler og andre former for interaktion
English: Table 3: Comparative Efficacy of Optaflu versus Placebo against Culture-Confirmed
Danish: Tabel 3: Sammenligning af Optaflus virkning i forhold til placebo mod kulturbekræftet influenza for hver undertype influenzavirus
English: - Paraesthesia
Danish: - Paræstesi
English: DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 01 June 2007
Danish: DATO FOR FØRSTE MARKEDSFØRINGSTILLADELSE/FORNYELSE
English: What Optaflu looks like and contents of the pack Optaflu is a suspension for injection in a pre-filled syringe (ready-to-use syringe).
Danish: Optaflu er en injektionsvæske, suspension i en fyldt injektionssprøjte (brugsklar sprøjte).
English: ** Seroconversion = negative pre-vaccination HI titer and post-vaccination HI titer ≥40; significant increase = positive pre-vaccination HI titer and at least a 4-fold increase in post-vaccination HI titer
Danish: * Serumbeskyttelse = HI-titre ≥ 40 ** Serokonvertering = negativ prævaccination-HI-titer og postvaccination-HI-titer ≥ 40; signifikant stigning
English: The following side effects have been observed during clinical trials and post-marketing surveillance:
Danish: Følgende bivirkninger er indberettet fra overvågning efter markedsføring med ægbaserede trivalente sæsonvacciner:
English: Optaflu suspension for injection in a pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
Danish: Optaflu injektionsvæske, suspension i fyldt injektionssprøjte Influenzavaccine (overfladeantigen, inaktiveret, tilberedt i cellekulturer)
English: Neuralgia, convulsion, febrile convulsion.
Danish: Neuralgi, kramper, feberkramper.
English: The active substances are influenza virus surface antigens (haemagglutinin and neuraminidase)*, inactivated, of the following strains:
Danish: Aktive stoffer: inaktiveret influenzavirus-overfladeantigener (hæmagglutinin og neuraminidase)*, fra følgende stammer:
English: Optaflu suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, prepared in cell cultures)
Danish: Optaflu injektionsvæske, suspension i fyldt injektionssprøjte Influenzavaccine (overfladeantigen, inaktiveret, fremstillet i cellekulturer)
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING MULTIPACK - Outer carton box for containing 2 carton boxes with 10 syringes each (with or without needles)
Danish: MÆRKNING, DER SKAL ANFØRES PÅ DEN YDRE EMBALLAGE FLERSTYKSPAKNING - Ydre kartonæske, der indeholder 2 kartonæsker med 10 injektionssprøjter i hver
English: - Extensive swelling of injected limb
Danish: - Kraftig hævelse i injiceret ekstremitet
English: Animal data have not shown effects on female fertility (see section 5.3).
Danish: Data fra dyrestudier indikerer ingen påvirkning af fertiliteten hos hundyr (se pkt.
English: This can be accompanied by several neurological signs such as transient visual disturbance, paraesthesia and tonic-clonic limb movements during recovery.
Danish: Synkope kan forekomme inden eller efter alle vaccinationer som en psykogen reaktion på injektionen og kan være ledsaget af adskillige neurologiske symptomer, såsom forbigående synsforstyrrelser, paræstesier og toniske-kloniske kramper under opvågningen.
English: 1 pre-filled syringe (0.5 ml) with needle 10 pre-filled syringes (0.5 ml) with needle 1 pre-filled syringe (0.5 ml) without needle 10 pre-filled syringes (0.5 ml) without needle
Danish: 1 fyldt injektionssprøjte (0,5 ml) med kanyle 10 fyldte injektionssprøjter (0,5 ml) med kanyle 1 fyldt injektionssprøjte (0,5 ml) uden kanyle 10 fyldte injektionssprøjter (0,5 ml) uden kanyle
English: Carton box for syringe(s) without needle - 1 pre-filled syringe (0.5 ml) without needle - 10 pre-filled syringes (0.5 ml) without needle
Danish: Kartonæske til injektionssprøjte(r) uden kanyle - 1 fyldt injektionssprøjte (0,5 ml) uden kanyle - 10 fyldte injektionssprøjter (0,5 ml) uden kanyle
English: Carton Box for syringe(s) with needle - 1 pre-filled syringe (0.5 ml) with needle - 10 pre-filled syringes (0.5 ml) with needle
Danish: Kartonæske til injektionssprøjte(r) med kanyle - 1 fyldt injektionssprøjte (0,5 ml) med kanyle - 10 fyldte injektionssprøjter (0,5 ml) med kanyle
English: shivering
Danish: Amning
English: 4.4 Special warnings and precautions for use
Danish: 6.4 Særlige opbevaringsforhold
English: 6.6 Special precautions for disposal and other handling
Danish: EVENTUELLE SÆRLIGE FORHOLDSREGLER VED BORTSKAFFELSE AF IKKE
English: Influenza virus surface antigens (haemagglutinin and neuraminidase)*, inactivated, of the following
Danish: ANGIVELSE AF AKTIVT STOF/AKTIVE STOFFER Influenzavirus-overfladeantigener (hæmagglutinin og neuraminidase)*, inaktiverede, fra følgende
English: B. CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE C. OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING
Danish: B. BETINGELSER ELLER BEGRÆNSNINGER VEDRØRENDE UDLEVERING OG
English: • gastrointestinal disorders such as abdominal pain, diarrhoea or disturbance of the digestive tract These reactions are usually mild and only last a few days.
Danish: • Mave-tarm-problemer som f.eks. mavesmerter, diarré eller forstyrrelser i fordøjelseskanalen.
English: PHARMACOLOGICAL PROPERTIES
Danish: Vaskulære sygdomme
English: Immunisation should be carried out on separate limbs.
Danish: Injektionerne bør i så tilfælde gives på forskellige ekstremiteter.
English: 5.3 Preclinical safety data
Danish: 6.3 Opbevaringstid
English: Tell your doctor immediately if you experience any of the following side effects - you may need
Danish: Søg omgående læge, hvis De får nogen af følgende bivirkninger - De kan have brug for lægehjælp: Ikke kendt (kan ikke estimeres ud fra forhåndenværende data):
English: Male fertility has not been assessed in animals (see section 5.3).
Danish: Der foreligger ingen dyrestudier vedrørende påvirkning af fertiliteten hos handyr (se pkt.
English: MARKETING AUTHORISATION HOLDER
Danish: MARKEDSFØRINGSTILLADELSESNUMMER (-NUMRE)
English: - If you have any further questions, ask your doctor, pharmacist or nurse.
Danish: - Spørg lægen, apotekspersonalet eller sundhedspersonalet, hvis der er mere, De vil vide.
English: 4.9 Overdose
Danish: 4.8 Bivirkninger
English: Musculoskeletal and connective tissue disorders
Danish: - Neurologisk e sygdomme såsom
English: Not known (cannot be estimated from the available data):
Danish: Ikke kendt (kan ikke estimeres ud fra forhåndenværende data): • følelsesløshed og snurrende fornemmelse
English: The European Commission granted a marketing authorisation valid throughout the European Union for Resolor on 15 October 2009.
Danish: Europa-Kommissionen udstedte en markedsføringstilladelse med gyldighed i hele Den Europæiske Union for Resolor den 15. oktober 2009.
English: It is available as tablets (1 and 2 mg).
Danish: Det leveres som tabletter (1 og 2 mg).
English: Other information about Resolor
Danish: Andre oplysninger om Resolor
English: The full EPAR for Resolor can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Danish: Den fuldstændige EPAR for Resolor findes på agenturets websted under: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: Resolor prucalopride
Danish: Resolor prucaloprid
English: This is a summary of the European public assessment report (EPAR) for Resolor.
Danish: Dette dokument er et sammendrag af den europæiske offentlige vurderingsrapport (EPAR) for Resolor.
English: A risk management plan has been developed to ensure that Resolor is used as safely as possible.
Danish: Der er udarbejdet en risikostyringsplan for at sikre, at Resolor anvendes så sikkert som muligt.
English: The patients had not responded well enough to previous treatment with laxatives.
Danish: Patienterne havde ikke reageret tilstrækkeligt på tidligere behandling med laksativer.
English: Resolor was more effective than placebo at treating chronic constipation.
Danish: Resolor var mere effektivt end placebo til behandling af kronisk forstoppelse.
English: For more information about treatment with Resolor, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Danish: Hvis du ønsker yderligere oplysninger om behandling med Resolor, kan du læse indlægssedlen (også en del af denne EPAR) eller kontakte din læge eller dit apotek.
English: When 5-HT binds to these receptors, it normally stimulates movement in the gut.
Danish: Når 5-HT binder sig til disse receptorer, stimulerer det normalt tarmbevægelserne.
English: What measures are being taken to ensure the safe and effective use of Resolor?
Danish: Hvilke foranstaltninger træffes der for at sikre risikofri og effektiv anvendelse af Resolor?
English: It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recommendations on the conditions of use for Resolor.
Danish: Det forklarer, hvordan Udvalget for Lægemidler til Mennesker (CHMP) vurderede lægemidlet og nåede frem til sin udtalelse til fordel for udstedelse af en markedsføringstilladelse og til sine anbefalinger om, hvordan Resolor skal anvendes.
English: Resolor is a medicine that contains the active substance prucalopride.
Danish: Resolor er et lægemiddel, der indeholder det aktive stof prucaloprid.
English: What is the risk associated with Resolor?
Danish: Hvilken risiko er der forbundet med Resolor?
English: This means that it works like a substance in the body called 5-hydroxytryptamine (5-HT, also known as serotonin) and attaches to receptors for 5-HT in the gut called ‘5-HT4 receptors'.
Danish: Det betyder, at det virker som et stof i kroppen kaldet 5-hydroxytryptamin (5-HT, også kendt som serotonin) og binder sig til receptorer for 5-HT i tarmene, de såkaldte "5-HT4-receptorer".
English: Patients aged over 65 years should start with a 1 mg dose once a day, and this can be increased to 2 mg once a day if needed.
Danish: Patienter over 65 år bør starte med en dosis på 1 mg én gang dagligt, som i givet fald kan øges til 2 mg én gang dagligt.
English: The active substance in Resolor, prucalopride, is a ‘5-HT4 receptor agonist'.
Danish: Det aktive stof i Resolor, prucaloprid, er en "5-HT4 receptoragonist".
English: It must also not be used in patients with intestinal perforation or obstruction, severe inflammatory conditions of the intestines such as Crohn's disease, ulcerative colitis (inflammation of the large intestine causing ulceration and bleeding) and toxic megacolon and megarectum (very serious complications of colitis).
Danish: Det må heller ikke gives til patienter med tarmperforation eller -obstruktion, svære inflammatoriske lidelser i tarmene såsom Crohns sygdom, colitis ulcerosa (betændelse i tyktarmen, som forårsager sårdannelse og blødning) og toksisk megacolon og megarectum (meget alvorlige komplikationer ved tyktarmsbetændelse).
English: The recommended dose of Resolor is 2 mg taken once a day.
Danish: Den anbefalede dosis Resolor er 2 mg én gang dagligt.
English: Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Resolor, including the appropriate precautions to be followed by healthcare professionals and patients.
Danish: På baggrund af denne er der anført sikkerhedsoplysninger i produktresuméet og indlægssedlen for Resolor, herunder passende forholdsregler, som patienter og sundhedspersonale skal følge.
English: The result from patients who received Resolor at the higher dose of 4 mg was similar to those who took the 2 mg dose.
Danish: Resultaterne for de patienter, der fik Resolor i den højere dosis på 4 mg, svarede til resultaterne for dem, der fik en dosis på 2 mg.
English: In the same way, when prucalopride attaches to and stimulates these receptors, it increases this movement and allows the bowels to empty faster.
Danish: Når prucaloprid binder sig til og stimulerer disse receptorer, øger det på samme måde disse bevægelser og bevirker, at tarmene kan tømmes hurtigere.
English: The CHMP decided that Resolor's benefits are greater than its risks and recommended that it be given marketing authorisation..
Danish: CHMP besluttede, at fordelene ved Resolor opvejer risiciene, og anbefalede udstedelse af en markedsføringstilladelse for Resolor.
English: Resolor must not be used in patients with kidney problems requiring dialysis (a blood clearance technique).
Danish: Resolor må ikke gives til patienter med nyreproblemer, der kræver dialyse (en blodrensningsteknik).
English: The most common side effects with Resolor (seen in more than 1 patient in 10) are headache, nausea (feeling sick), diarrhoea and abdominal (tummy) pain.
Danish: De hyppigste bivirkninger ved Resolor (som optræder hos flere end 1 ud af 10 patienter) er hovedpine, kvalme, diarré og mavesmerter.
English: The main measure of effectiveness in the studies was the number of patients who completely emptied their bowels at least three times a week over a 12 week period without the help of laxatives.
Danish: Undersøgelsernes primære effektmål var antallet af patienter, som fik udtømt deres tarme fuldstændigt mindst tre gange om ugen over en periode på 12 uger uden hjælp af laksativer.
English: Resolor is used to treat symptoms of chronic (long-term) constipation in adults for whom laxatives (medicines that trigger bowel movements) do not work well enough.
Danish: Resolor anvendes til behandling af symptomer på kronisk (langvarig) forstoppelse hos voksne, for hvem laksativer (afføringsmidler) ikke har tilstrækkelig effekt.
English: Why has Resolor been approved?
Danish: Hvorfor blev Resolor godkendt?
English: Resolor 2 mg once a day was also compared with placebo in another main study involving 374 men with chronic constipation.
Danish: Resolor i doser på 2 mg én gang dagligt blev også sammenlignet med placebo i en anden hovedundersøgelse, der omfattede 374 mænd med kronisk forstoppelse.